Immix Biopharma, Inc. (IMMX)
14.07
-0.40
(-2.76%)
USD |
NASDAQ |
Aug 26, 16:00
14.50
+0.43
(+3.06%)
After-Hours: 20:00
Immix Biopharma Price : 14.07 for Aug. 26, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 26, 2026 | 14.45 | 14.55 | 13.80 | 14.07 | 1.385M |
| Aug 25, 2026 | 13.60 | 15.10 | 13.48 | 14.47 | 3.661M |
| Aug 24, 2026 | 13.66 | 13.80 | 12.90 | 13.61 | 1.416M |
| Aug 21, 2026 | 13.36 | 13.76 | 13.12 | 13.66 | 1.511M |
| Aug 20, 2026 | 12.98 | 13.20 | 12.69 | 13.16 | 1.666M |
| Aug 19, 2026 | 11.99 | 13.19 | 11.99 | 13.19 | 1.975M |
| Aug 18, 2026 | 11.12 | 11.86 | 11.06 | 11.81 | 1.353M |
| Aug 17, 2026 | 10.88 | 11.53 | 10.74 | 11.34 | 1.249M |
| Aug 14, 2026 | 10.85 | 11.08 | 10.36 | 10.97 | 1.295M |
| Aug 13, 2026 | 11.51 | 11.55 | 10.82 | 10.92 | 1.142M |
| Aug 12, 2026 | 11.49 | 11.72 | 10.93 | 11.37 | 1.549M |
| Aug 11, 2026 | 10.14 | 11.55 | 9.92 | 11.49 | 1.821M |
| Aug 10, 2026 | 9.755 | 10.33 | 9.66 | 10.13 | 1.600M |
| Aug 07, 2026 | 10.24 | 10.31 | 9.25 | 9.72 | 1.605M |
| Aug 06, 2026 | 9.52 | 10.10 | 9.52 | 10.06 | 1.220M |
| Aug 05, 2026 | 9.54 | 9.74 | 9.28 | 9.54 | 1.317M |
| Aug 04, 2026 | 8.53 | 9.38 | 8.53 | 9.33 | 1.869M |
| Aug 03, 2026 | 8.27 | 8.43 | 7.83 | 8.42 | 1.618M |
| Jul 31, 2026 | 8.61 | 8.720 | 8.21 | 8.32 | 1.591M |
| Jul 30, 2026 | 8.28 | 8.63 | 8.26 | 8.55 | 1.299M |
| Jul 29, 2026 | 8.47 | 8.66 | 8.12 | 8.17 | 1.368M |
| Jul 28, 2026 | 8.63 | 8.841 | 8.10 | 8.44 | 1.686M |
| Jul 27, 2026 | 8.63 | 9.390 | 8.58 | 8.69 | 1.990M |
| Jul 24, 2026 | 8.88 | 8.99 | 8.48 | 8.52 | 2.319M |
| Jul 23, 2026 | 9.23 | 9.455 | 8.775 | 8.80 | 995837.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Savara, Inc. | 5.61 |
| SELLAS Life Sciences Group, Inc. | 13.73 |
| Atossa Therapeutics, Inc. | 2.65 |
| Marker Therapeutics, Inc. | 1.45 |
| Krystal Biotech, Inc. | 359.76 |
Price Related Metrics
| PEG Ratio | -1.426 |
| Price to Book Value | 4.397 |
| Earnings Yield | -6.26% |
| Market Cap | 1.007B |
| PEGY Ratio | -1.426 |